Recorded on March 4th, 2022

Click "Register" to access the recording.

Training program on new long-acting HIV injectable Cabotegravir for PrEP and Cabotegravir/Rilpivirine for treatment. Dr. Amy Colson addresses efficacy, benefits and challenges of long-acting injectables, where and how to administer, dosing schedules, and comparisons to oral medication. 

Speaker:
Amy Colson, MD
Research Director
Community Research Initiative

Continuing education credit is not available for this recording.